Related Experiment Video
Updated: Jun 7, 2025
07:08
Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
5.6K
Motif-guided identification of KRAS-interacting proteins
Sanan Wu1,2, Xiaoyang Gao1,2, Di Wu1,2
1Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China.
BMC Biology
|November 20, 2024
Summary
Researchers developed a novel workflow to identify KRAS-interacting proteins, crucial for understanding cancer and developing new therapies. This method successfully predicted and validated GRB10 as a new KRAS binding partner.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- KRAS is a significant but challenging target in cancer drug discovery.
- KRAS regulates cancer progression via protein-protein interactions, with many partners yet unidentified.
Purpose of the Study:
- To develop and validate a computational workflow for predicting novel KRAS-interacting proteins.
- To identify new therapeutic targets by understanding KRAS-driven tumor mechanisms.
Main Methods:
- Utilized 17 KRAS-interacting motifs as queries for structure-based similarity searches in a human protein database.
- Employed an in-house prediction method, PPI-Miner, to identify potential KRAS interactors.
- Experimentally validated predictions using biolayer interferometry, immunofluorescence, and co-immunoprecipitation.
Main Results:
- Predicted 78 potential KRAS-interacting proteins; 10 were selected for validation.
- Identified 4 proteins with binding affinities to KRAS, including GRB10.
- Confirmed the interaction of GRB10 (RA-PH domain) with KRAS using biochemical and cellular assays.
Conclusions:
- The developed workflow effectively predicts KRAS-interacting proteins.
- Findings enhance understanding of KRAS-driven cancers and inform therapeutic strategy development.
Related Concept Videos
02:04Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
01:07MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K